Mezym F (Pancreas Powder From Porcine)

Mezym F (pancreatin) provides pancreatic enzyme replacement for disorders characterized by insufficient digestive enzyme production.

• Exocrine pancreatic insufficiency: improves digestion and nutrient absorption.
• Cystic fibrosis: aids breakdown of fats, proteins, and carbohydrates to support nutritional status.
• Chronic pancreatitis: compensates for reduced endogenous enzyme output to reduce steatorrhea.
• Pancreatic enzyme replacement therapy: restores normal digestive function in patients lacking pancreatic secretions.

• Pancreatin supplies exogenous pancreatic enzymes—lipase, amylase, and protease—that act in the duodenum to hydrolyze dietary fats, carbohydrates, and proteins. By breaking these macronutrients into absorbable units, the preparation facilitates their uptake across the intestinal mucosa, compensating for deficient endogenous pancreatic secretion.

Adverse reactions may occur with any pancreatic enzyme preparation. Most are mild and reversible.

Common Side Effects

• Abdominal discomfort or cramping.
• Flatulence or bloating.
• Diarrhea or loose stools.
• Nausea or mild vomiting.
• Constipation.
• Oily or fatty stools.

Serious or Rare Side Effects

• Allergic reactions such as rash, urticaria, or anaphylaxis.
• Severe abdominal pain indicating possible pancreatitis.
• Intestinal obstruction or blockage.
• Respiratory distress or bronchospasm.
• Significant elevation of serum amylase.
• Unexplained weight loss despite therapy.

Use of Mezym F requires careful clinical monitoring and patient education.

• Dose individualization: adjust based on clinical response and stool fat content.
• Monitor nutritional status: regularly assess weight, vitamin levels, and growth in children.
• Assess for hypersensitivity: discontinue if signs of allergic reaction appear.
• Administer with meals and snacks: ensures enzymes contact ingested food for optimal activity.
• Avoid concurrent use of certain acid‑reducing agents without dose adjustment.
• Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Pancreatin may interact with other medications that affect gastric acidity or fat digestion.

Major Interactions (Avoid)

• Proton pump inhibitors: can reduce enzyme activity and efficacy.
• Antacids containing aluminum or magnesium: may bind enzymes and diminish their action.
• Orlistat: interferes with fat digestion, potentially reducing the benefit of pancreatic enzymes.

Moderate Interactions (Monitor Closely)

• H2‑blockers (e.g., ranitidine): may require enzyme dose increase.
• Bile‑acid sequestrants (e.g., cholestyramine): can bind enzymes, lowering their availability.
• High‑dose corticosteroids: may affect gastrointestinal absorption of enzymes.